Recorded Chinese product: 三磷酸腺苷二钠注射液三磷酸腺苷二钠注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江西银涛药业有限公司Chinese legal name: 江西银涛药业有限公司
主要成分Active Ingredients
- 三磷酸腺苷二钠Sanlin Suanxian Ganer Na
药物知识说明
三磷酸腺苷二钠是一种在国家药监局注册认定的药品。该药品含有三磷酸腺苷二钠-15eca7d7等成分。
该药品关联的活性成分包括:三磷酸腺苷二钠Sanlin Suanxian Ganer Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:江西银涛药业有限公司Chinese legal name: 江西银涛药业有限公司。
您可以探索含有相同成分的其他药品:三磷酸腺苷二钠-15eca7d7成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 三磷酸腺苷二钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 三磷酸腺苷二钠Sanlin Suanxian Ganer Na.
Manufacturers recorded for this product: 江西银涛药业有限公司Chinese legal name: 江西银涛药业有限公司.
Explore other medicines containing the same ingredient: 三磷酸腺苷二钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 三磷酸腺苷二钠注射液Recorded Chinese product: 三磷酸腺苷二钠注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:20mg2 mL:20 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江西银涛药业有限公司Chinese legal name: 江西银涛药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H36021198
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H36021198
Manufacturer
Chinese legal name: 江西银涛药业有限公司
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H36021198
生产企业
江西银涛药业有限公司
适应症
辅酶类药。用于进行性肌萎缩、脑出血后遗症、心功能不全、心肌疾患及肝炎等的辅助治疗。
用法用量
肌内注射或静脉注射,一次10~20mg,一日10~40mg。
不良反应
1.呼吸系统 可见咳嗽、胸闷及暂时性呼吸困难,有哮喘病史者可能诱发哮喘。2.心血管系统 可见低血压。转复心律时有短暂的心脏停博。3.肝脏 极少数患者可出现一过性丙氨酸氨基转移酶升高。4.肌肉骨骼系统 大剂量肌内注射,少数患者可出现关节酸痛和下肢痛。5.过敏反应 少见荨麻疹,偶见过敏性休克。6.全身反应 可见发热、头晕。转复心律后可出现乏力。7.局部反应 大剂量肌内注射可引起局部疼痛。8.消化系统 可见呃逆。
禁忌
本药对窦房结有明显抑制作用,因此对病窦综合征或窦房结功能不全或老年人慎用或不用
注意事项
1.脑出血初期患者禁用。
2.当药品性状发生改变时禁止使用。
贮藏
密闭,在凉暗处保存。
规格
2ml:20mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.